Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition.
暂无分享,去创建一个
H. Dvorak | J. Nagy | A. Dvorak | L. Brown | L. Water | J A Nagy | D. Senger | H F Dvorak | A M Dvorak | L F Brown | L. Van De Water | D R Senger | N Lanir | L Van de Water | N. Lanir | N. Lanir | Lawrence F. Brown
[1] S. Robbins,et al. Pathologic basis of disease , 1974 .
[2] W. Dewey,et al. 131I‐labeled antibodies to human fibrinogen. Diagnostic studies and therapeutic trials , 1967, Cancer.
[3] M. Carr,et al. Influence of factor XIII and fibronectin on fiber size and density in thrombin-induced fibrin gels. , 1987, The Journal of laboratory and clinical medicine.
[4] R. Colvin. FIBRINOGEN‐FIBRIN INTERACTIONS WITH FIBROBLASTS AND MACROPHAGES * , 1983, Annals of the New York Academy of Sciences.
[5] H. Dvorak,et al. Quantitation of fibrinogen influx and fibrin deposition and turnover in line 1 and line 10 guinea pig carcinomas. , 1984, Cancer research.
[6] G. Majno,et al. Postoperative peritoneal adhesions. A study of the mechanisms. , 1971, The American journal of pathology.
[7] K. Danø,et al. Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.
[8] L. Furcht. Critical factors controlling angiogenesis: cell products, cell matrix, and growth factors. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[9] K. L. Moore,et al. Peritoneal fibrinolysis: evidence for the efficiency of the tissue-type plasminogen activator. , 1983, The Journal of laboratory and clinical medicine.
[10] E. Haber,et al. Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen. , 1983, Science.
[11] B. Hosein,et al. Monocyte receptors for fibronectin characterized by a monoclonal antibody that interferes with receptor activity , 1985, The Journal of experimental medicine.
[12] H. Dvorak,et al. Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. , 1987, Laboratory investigation; a journal of technical methods and pathology.
[13] W. Hancock,et al. Antimetastatic Agents. I. Role of Cellular Procoagulants in the Pathogenesis of Fibrin Deposition in Cancer and the Use of Anticoagulants and/or Antiplatelet Drugs in Cancer Treatment , 1988, Seminars in thrombosis and hemostasis.
[14] R. O’meara,et al. Cytological observations on carcinoma , 1958, Irish journal of medical science.
[15] M. Scully,et al. Fibrin subunits in venous and arterial thromboembolism. , 1976, Cardiovascular research.
[16] E. Brown,et al. Fibronectin receptors of phagocytes. Characterization of the Arg-Gly- Asp binding proteins of human monocytes and polymorphonuclear leukocytes , 1988, The Journal of experimental medicine.
[17] W. Dewey. Vascular-extravascular exchange of II31 plasma proteins in the rat. , 1959, The American journal of physiology.
[18] E. Manseau,et al. Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression. , 1979, Journal of the National Cancer Institute.
[19] R. Hynes. Fibronectins: a family of complex and versatile adhesive glycoproteins derived from a single gene. , 1985, Harvey lectures.
[20] Anita B. Roberts,et al. Autocrine growth factors and cancer , 1985, Nature.
[21] R. Ross,et al. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. , 1975, The American journal of pathology.
[22] S. W. O'Connor,et al. Accessibility of circulating immunoglobulin G to the extravascular compartment of solid rat tumors. , 1984, Cancer research.
[23] J. Vermylen,et al. CLOTTING AND FIBRINOLYTIC ACTIVITIES IN PERITONEAL FLUID , 1981, British journal of obstetrics and gynaecology.
[24] C. Heldin,et al. Growth factors: Mechanism of action and relation to oncogenes , 1984, Cell.
[25] A. Buczyński,et al. Cryptic and active plasminogen activators secreted by line 10 tumor cells in culture. , 1983, Cancer research.
[26] E. Brown,et al. Interaction of culture-derived macrophages with the fibroblast-binding domain of fibronectin is a necessary but inefficient signal for fibronectin enhancement of CR1-mediated phagocytosis. , 1986, Journal of immunology.
[27] M. Key,et al. Partial purification and characterization of a vascular permeability factor secreted by a human colon adenocarcinoma cell line , 1985, International journal of cancer.
[28] B. Kudryk,et al. Specificity of a monoclonal antibody for the NH2-terminal region of fibrin. , 1984, Molecular immunology.
[29] R. Clark,et al. Fibronectin fragment(s) are chemotactic for human peripheral blood monocytes. , 1982, Journal of immunology.
[30] M. Yamagata,et al. Chondroitin sulfate proteoglycan (PG-M-like proteoglycan) is involved in the binding of hyaluronic acid to cellular fibronectin. , 1986, The Journal of biological chemistry.
[31] Gary R. Grotendorst,et al. Increased content of Type V Collagen in desmoplasia of human breast carcinoma. , 1982, The American journal of pathology.
[32] U. Delvos,et al. Binding of Fibrinogen to Cultured Bovine Endothelial Cells , 1985, Thrombosis and Haemostasis.
[33] H. Dvorak,et al. Fibrinogen influx and accumulation of cross-linked fibrin in mouse carcinomas. , 1988, Cancer research.
[34] P. Shubik,et al. Vascularization induced in the cheek pouch of the Syrian hamster by tumor and nontumor substances. , 1976, Journal of the National Cancer Institute.
[35] H. Dvorak,et al. Macrophage migration in fibrin gel matrices. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[36] J. Levin,et al. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. , 1977 .
[37] E. Manseau,et al. Human breast carcinoma: fibrin deposits and desmoplasia. Inflammatory cell type and distribution. Microvasculature and infarction. , 1981, Journal of the National Cancer Institute.
[38] L. Van De Water,et al. Alteration of fibronectin receptors (integrins) in phorbol ester-treated human promonocytic leukemia cells. , 1988, Cancer research.
[39] J. Folkman,et al. The effect of fibrin on cultured vascular endothelial cells. , 1979, Tissue & cell.
[40] R. Clark. Fibronectin in the skin. , 1983, The Journal of investigative dermatology.
[41] D. Granger,et al. 4 – Permeability Characteristics of the Mircocirculation , 1983 .
[42] G. Tremblay. Stromal aspects of breast carcinoma. , 1979, Experimental and molecular pathology.
[43] A. Mantovani,et al. Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. , 1985, Journal of Clinical Investigation.
[44] H. Dvorak. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.
[45] N. Catsimpoolas,et al. Lipid angiogenic factor from omentum. , 1984, JAMA.
[46] L. Heuser,et al. Differential macromolecular leakage from the vasculature of tumors , 1986, Cancer.
[47] M. E. Parker,et al. Antigenic markers on fragment DD, a unique plasmic derivative of human crosslinked fibrin , 1979 .
[48] M. Sporn,et al. Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo. , 1983, Science.
[49] H. Dvorak,et al. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. , 1988, The American journal of pathology.
[50] H. Dvorak,et al. Tumor shedding and coagulation. , 1981, Science.
[51] R. Ross,et al. The biology of platelet-derived growth factor , 1986, Cell.
[52] D. Pressman,et al. Localization in vivo of radio-iodinated anti-rat-fibrin antibodies and radio-iodinated rat fibrinogen in the Murphy rat lymphosarcoma and in other transplantable rat tumors. , 1959, Journal of the National Cancer Institute.
[53] J. Henderson,et al. Analysis of Twenty‐three Plasma Proteins in Ascites The Depletion of Fibrinogen and Plasminogen , 1980, Annals of surgery.
[54] H. Dvorak,et al. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. , 1986, Cancer research.
[55] R. Jain,et al. Microvascular permeability of normal and neoplastic tissues. , 1986, Microvascular research.
[56] M. Sporn,et al. Peptide growth factors and inflammation, tissue repair, and cancer. , 1986, The Journal of clinical investigation.
[57] M. White,et al. Epithelial wound healing enhanced by transforming growth factor-alpha and vaccinia growth factor. , 1987, Science.
[58] Trelstad Rl. Glycosaminoglycans: mortar, matrix, mentor. , 1985 .
[59] E. Ruoslahti,et al. Arg-Gly-Asp: A versatile cell recognition signal , 1986, Cell.
[60] J. L. Bethune,et al. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. , 1985, Biochemistry.
[61] M. Sporn,et al. Transforming growth factor-beta: biological function and chemical structure. , 1986, Science.
[62] S. Wright,et al. Fibronectin receptor of human macrophages recognizes the sequence Arg- Gly-Asp-Ser , 1985, The Journal of experimental medicine.
[63] K. Mann,et al. Coordinate binding of factor Va and factor Xa to the unstimulated platelet. , 1981, The Journal of biological chemistry.
[64] C. Song,et al. Quantitative study of vascularity in Walker carcinoma 256. , 1971, Cancer research.
[65] A. Guyton,et al. Textbook of Medical Physiology , 1961 .
[66] C. Dang,et al. Disorganization of cultured vascular endothelial cell monolayers by fibrinogen fragment D. , 1985, Science.
[67] S. Pizzo,et al. The effect of fibrin-stabilizing factor on the subunit structure of human fibrin. , 1971, The Journal of clinical investigation.
[68] R. Montesano,et al. Phorbol ester stimulates macrophage invasion of fibrin matrices , 1988, The Anatomical record.
[69] K. Mann,et al. Tumor cell generation of thrombin via functional prothrombinase assembly. , 1985, Cancer research.
[70] E. Jentzsch,et al. Is the formation of fibrin a necessary event for the initiation of angiogenic responses in the chick chorioallantoic membrane? , 1982, Experimental pathology.
[71] Gary R. Grotendorst,et al. Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. , 1985, The Journal of clinical investigation.
[72] W. Thompson,et al. Fibrin degradation and angiogenesis: Quantitative analysis of the angiogenic response in the chick chorioallantoic membrane , 1985, The Journal of pathology.
[73] J. Finlayson,et al. The ɛ-(γ-Glutamyl)Lysine Crosslink and the Catalytic Role of Transglutaminases , 1977 .
[74] D. Pressman,et al. Fibrin in human tumors. , 1960, Cancer research.
[75] H. Dvorak,et al. Macrophage migration in fibrin gel matrices. II. Effects of clotting factor XIII, fibronectin, and glycosaminoglycan content on cell migration. , 1988, Journal of immunology.
[76] E. Ruoslahti,et al. Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor , 1985, Cell.
[77] N. Harris,et al. Fibrin deposits in Hodgkin's disease. , 1982, The American journal of pathology.
[78] W. Konigsberg,et al. Purification and characterization of bovine tissue factor. , 1981, The Journal of biological chemistry.
[79] A. Chong,et al. Cell surface receptors for sulphated polysaccharides: a potential marker for macrophage subsets. , 1986, Immunology.
[80] T. K. Hunt,et al. Role of Platelets and Fibrin in the Healing Sequence: An In Vivo Study of Angiogenesis and Collagen Synthesis , 1982, Annals of surgery.
[81] R. Nicosia,et al. Angiogenesis-dependent tumor spread in reinforced fibrin clot culture. , 1983, Cancer research.
[82] K. Yamada,et al. Characterization of fibronectin interactions with glycosaminoglycans and identification of active proteolytic fragments. , 1980, The Journal of biological chemistry.
[83] E. Manseau,et al. Pathogenesis of desmoplasia. I. Immunofluorescence identification and localization of some structural proteins of line 1 and line 10 guinea pig tumors and of healing wounds. , 1984, Journal of the National Cancer Institute.
[84] J. Hirsh,et al. TUMORS, MUCUS PRODUCTION, AND HYPERCOAGULABILITY , 1974, Annals of the New York Academy of Sciences.
[85] B. Blombäck,et al. Fibrin gel structure and clotting time. , 1982, Thrombosis research.
[86] O. Wilhelm,et al. Fibrinolysis in ascitic fluid: isolation and characterization of fibrin derivatives, their interaction with albumin. , 1987, Thrombosis research.
[87] R. Clark,et al. Fibronectin in basal cell epithelioma: sources and significance. , 1984, The Journal of investigative dermatology.
[88] J. Hermans,et al. Fibrin: Structure and Interactions , 1982, Seminars in thrombosis and hemostasis.
[89] I. Carr,et al. The ultrastructure and permeability characteristics of the blood vessels of a transplantable rat sarcoma , 1972, The Journal of pathology.
[90] H. Dvorak,et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.
[91] J. Folkman,et al. Mast cells and tumor angiogenesis , 1976, International journal of cancer.
[92] L. Heuser,et al. Human malignant ascites and histamine-induced protein leakage from the normal microcirculation. , 1988, Microvascular research.
[93] R. Doolittle,et al. The amino acid sequence of the α-chain of human fibrinogen , 1979, Nature.
[94] U. Delvos,et al. The Mechanism of Fibrin‐Induced Disorganization of Cultured Human Endothelial Cell Monolayers , 1986, Arteriosclerosis.
[95] R. Tucker,et al. Morphology and behavior of quail neural crest cells in artificial three-dimensional extracellular matrices. , 1984, Developmental biology.
[96] H. Dvorak,et al. Regulation of extravascular coagulation by microvascular permeability. , 1985, Science.
[97] THE CONVERSION OF FIBRINOGEN TO FIBRIN: EVENTS AND RECOLLECTIONS FROM 1942 TO 1982 * , 1983, Annals of the New York Academy of Sciences.